iShares Biotechnology ETF (NASDAQ:IBB) Stock Holdings Lessened by Liberty Wealth Management LLC

Liberty Wealth Management LLC lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,970 shares of the financial services provider’s stock after selling 189 shares during the period. Liberty Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $545,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of IBB. Global Assets Advisory LLC bought a new position in shares of iShares Biotechnology ETF during the first quarter valued at approximately $66,059,000. BNP Paribas Financial Markets grew its stake in iShares Biotechnology ETF by 25.7% during the 1st quarter. BNP Paribas Financial Markets now owns 2,055,373 shares of the financial services provider’s stock worth $282,038,000 after buying an additional 420,053 shares during the last quarter. Gray Foundation acquired a new stake in iShares Biotechnology ETF in the fourth quarter worth $17,890,000. Jane Street Group LLC bought a new stake in iShares Biotechnology ETF in the first quarter valued at $14,386,000. Finally, Miller Investment Management LP boosted its holdings in shares of iShares Biotechnology ETF by 2,394.4% during the fourth quarter. Miller Investment Management LP now owns 90,122 shares of the financial services provider’s stock valued at $12,243,000 after acquiring an additional 86,509 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $144.53 on Tuesday. The company has a 50-day simple moving average of $144.27 and a 200-day simple moving average of $138.08. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.17.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.